Blincyto 38.5 mcg

Blincyto 38.5 mcg is a medicine authorised by Swissmedic under authorisation number 65654. The authorisation holder is Amgen Switzerland AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 25 February 2016 and the authorisation is valid without a time limit. ATC code L01FX07 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 65654
  • ATC L01FX07
  • Biotechnological medicines
Authorisation data
Authorisation number65654
NameBlincyto 38.5 mcg
Full nameBlincyto 38.5 mcg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderAmgen Switzerland AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FX07
First authorisation25 February 2016
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Blincyto 38.5 mcg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA25 February 2016

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01FX0707.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Blincyto 38.5 mcg authorised in Switzerland?

Yes. Blincyto 38.5 mcg is authorised by Swissmedic under authorisation number 65654, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Blincyto 38.5 mcg have?

Blincyto 38.5 mcg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Blincyto 38.5 mcg?

The authorisation holder is Amgen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com